TOKYO -- Japan's Mitsubishi Chemical Group has granted a first refusal right to U.S. investment fund Bain Capital for the sale of its pharmaceutical subsidiary Mitsubishi Tanabe Pharma, Nikkei has ...
Some results have been hidden because they may be inaccessible to you